Influence of zeranol and breed on growth, composition of gain, and plasma hormone concentrations.

Seven Angus and six Brangus steers averaging 225 and 245 kg, respectively, were assigned randomly to zeranol (36 mg) implant (I) and no implant (NI) treatments. Steers had ad libitum access to a corn silage diet plus .68 kg of a soybean meal-based supplement fed daily. Steers were bled via jugular catheters on d 0, 28, 56, and 84 at 15-min intervals for 4 h before and 4 h after feeding. Concentrations of growth hormone (GH), insulin (INS), triiodothyronine (T3), thyroxine (T4), and glucose were determined. Whole-body protein and fat contents were monitored. A breed x I interaction (for d 56 to 84 and d 0 to 84) was observed for ADG (P less than .05 and P less than .07, respectively), feed conversion (P less than .05 and P less than .07, respectively), and protein deposition (for d 0 to 29 and d 0 to 84; P less than .07 and P less than .05, respectively). These interactions were attributed to a greater response to I by Angus than by Brangus steers. A feeding x period interaction (P less than .10) was observed for mean GH concentration, and INS, T4, and T3 concentrations were higher (P less than .05) during the 4-h postfeeding period than during the 4-h prefeeding period. The implant increased (P less than .08) mean GH concentration but did not alter the frequency, duration, or amplitude of plasma GH peaks. Steers that were implanted had lower (P less than .05) plasma T3. Brangus steers had lower (P less than .05) plasma glucose, T3, and T4 concentrations than Angus steers. Results indicate that growth factors beyond those measured are responsible for the anabolic response to zeranol.

Dynamics of gonadotropin release following ovariectomy and injection of gonadotropin-releasing hormone in early postpartum dairy cows.

The influence of the ovary and of injection of low doses of gonadotropin-releasing hormone on secretion and gonadotropin-releasing hormone-induced release of gonadotropins in early postpartum cows was examined in a 2 x 2 factorial design (6 cows/group). Twelve cows were ovariectomized 2 d postpartum (calving = d 0; groups 1 and 2) and 12 cows were left intact (groups 3 and 4). Groups 1 and 3 received gonadotropin-releasing hormone (5 micrograms) every 120 min for 70 h from d 6 to d 9; groups 2 and 4 received saline by the same regimen. All animals received 50 micrograms gonadotropin-releasing hormone on d 9. Mean concentrations of FSH were higher following ovariectomy compared with those of intact cows 6 to 8 d postpartum, whereas no differences in FSH were observed between cows receiving gonadotropin-releasing hormone or saline during this period. Concentrations of LH were similar in intact and ovariectomized cows on d 6 to 8 but were increased in cows receiving gonadotropin-releasing hormone compared with cows receiving saline. Ovariectomy did not alter the gonadotropin-releasing hormone-induced release of gonadotropins on d 9. Injection of gonadotropin-releasing hormone on d 6 to 8 resulted in a decreased gonadotropin-releasing hormone-induced release of gonadotropins on d 9. It was concluded that removal of ovarian influence resulted in increased secretion of FSH but did not affect gonadotropin-releasing hormone-induced release of LH and FSH during the early postpartum period.

Influence of frame size and zeranol on growth, compositional growth and plasma hormone characteristics.

A 2 X 2 factorially arranged trial was conducted to compare effects of implant (zeranol) and frame size on weight and compositional gain, and plasma hormone concentrations. Angus, Charolais X Hereford and Hereford X Angus yearling steers (34 steers averaging 270 kg body weight) were randomly assigned to treatments of small (SF) vs large frame (LF) and implant (I) vs no implant (NI). Steers were implanted at 0 and 97 d and individually fed an 81% whole shelled corn and 11.5% corn silage-based diet (dry basis) for a 175-d period. Shrunk weights and body measurements for frame size determination were taken initially and at approximately 28-d intervals; blood was collected via venipuncture at 14-d intervals for analyses of insulin (IN), triiodothyronine (T3), thyroxine (T4) and glucose concentrations. Steers were also counted in a whole body counter for measurement of 40K content and prediction of whole body protein and fat. The I steers showed an improvement (P less than .05) in daily gain regardless of frame size for the total trial. The I LF steers required 18% more dry matter to attain higher daily gain for 97 to 175 d; I steers were more efficient (P less than .05) at converting dry matter to gain during 0 to 97 d and 0 to 175 d. Daily fat deposition was increased (P less than .05) in I steers, while protein deposition was not affected by I. Plasma IN concentrations were numerically elevated (P less than .10) in I steers regardless of frame size, during the initial 97 d. Implant did not influence (P greater than .10) plasma T3, T4 and glucose concentrations regardless of frame size. Steers responded differently to zeranol implant over time regarding plasma T4 concentrations (P less than .003). Steers differing in frame size responded similarly in rate of gain, in feed conversion and in patterns of plasma insulin concentrations to zeranol implants.

Effect of intrauterine infusion of Escherichia coli endotoxin in postpartum pony mares.

Fifteen pony mares were assigned to 1 of 3 treatment groups after foaling: Group 1, 35 ml of sterile saline solution was infused into the uterine lumen within 24 hours after parturition (6 mares); group 2, 300 mg of Escherichia coli endotoxin was infused into the uterine lumen within 24 hours after parturition (6 mares); and group 3, 300 mg of E coli endotoxin was infused into the uterine lumen between 72 and 96 hours after parturition (3 mares). Rectal temperatures were taken at -1, -0.5, 0, 0.5, 1, 1.5, 2, 3, 4, and 5 hours after treatment. Venous blood samples were also taken at these times for routine WBC counts. Data were analyzed as a repeated measurement design with linear and quadratic orthogonal contrasts performed where significant time and interaction with time occurred. Pretreatment averages of total WBC and neutrophil counts were compared with their nadir posttreatment averages by a t test when treatment-by-time interaction was significant for the parameter. Rectal temperature (37.9 +/- 0.1 C) remained stable and did not vary among treatment groups after intrauterine infusions. In contrast, total WBC and neutrophil counts did vary among treatment groups across time. However, for treatment groups 1 and 3, neither blood total WBC count nor neutrophil count after intrauterine infusions was different from pretreatment observations. In group 2, total WBC count decreased (P less than 0.10) from a pretreatment average of 11.5 +/- 0.4 X 10(3) cells/mm3 to a nadir concentration of 10.0 +/- 0.6 X 10(3) cells/mm3 by 60 minutes after infusion of endotoxin into the uterus.(ABSTRACT TRUNCATED AT 250 WORDS)

Effects of intrauterine infusion of Escherichia coli endotoxin in anestrous and steroid treated pony mares.

This study was conducted to determine if Escherichia coli endotoxin was absorbed from the equine uterus and if exogenous progesterone and estrogen affected the absorption of intrauterine endotoxin. Six mature anestrous pony mares were used in three consecutive crossover experiments (Periods) with a 14 day recovery between each period. Mares were randomly assigned to one of two treatment groups (three mares per group) and received an intrauterine infusion of either saline or endotoxin. Treatment groups were reversed and readministered after 14 days completing a crossover design (Period 1). During Periods 2 and 3 the mares were treated with estradiol-17beta (4.0 mg/day) or progesterone (400 mg/day), respectively, for 5 days prior to receiving intrauterine infusions. On the day of intrauterine infusions rectal temperatures and jugular blood samples were obtained at 30 to 60 minute intervals. Blood samples were analyzed for total white blood cell counts and by Limulus Amebocyte Lysate Assays. There were no significant alterations in the observed parameters among the various treatment groups. These results indicated that intrauterine E. coli endotoxin was not absorbed from the uterus of anestrous pony mares in large enough amounts to produce a morbid condition and that prior exposure to exogenous progesterone or estradiol-17beta did not affect the absorption of endotoxin from the equine uterus.

Chronological profiles of prolactin and growth hormone in lactating cows.

Prolactin and growth hormone were measured in blood plasma at 30-min intervals for three consecutive 24-h periods in 6 cows during midlactation. Concentrations of prolactin in milk and yields of milk also were quantified. Prolactin in blood plasma appeared to have a 24-h rhythm as well asd a 6-h rhythm by time series spectral analysis. Lowest prolactin occurred between 0600 and 0900 h each day, whereas maximums occurred between 1030 and 1600 h. Neither milk prolactin concentration nor yield of milk differed between milkings at 0530 and 1730 h. Concentration of prolactin in milk was not significantly correlated with prolactin concentration of plasma. However, prolactin of plasma averaged over the 12-h prior to milking was associated significantly with yield of milk and with total quantity of milk prolactin removed at that milking.

Relationship between tachycardia, prolactin and growth hormone in conscious ewes.

Brief episodes of apparently unprovoked tachycardia (increased heart rate, HR) lasting about 10--20 min were observed about one h after initiation of experimentation in 10 ovariectomized ewes which were fitted with indwelling vascular cannulae. The incidence of tachycardia episodes varied among ewes, but 99 of 215 (46%) sampling trials contained such an episode (mean HR increase = 34 beats/min). Approximately 30--40 min after maximum tachycardia when HR had returned to basal rates, both plasma prolactin (Prl) and growth hormone (GH) increased significantly from the nadir concentrations that had been observed around the time of maximum tachycardia and shortly thereafter. There were no changes in packed cell volume (PCV) and only brief changes in mean arterial blood pressure related to the tachycardia. There was a mild trembling behavior associated with many of the tachycardia episodes. The causes for the tachycardia are not known. Heparin administration did not seem to be involved, but physical stimulation inside the jugular vein, while not essential, may increase the incidence of tachycardia episodes.

Hormone induced lactation in the cow. IV. Relationships between lactational performance and hormone concentrations in blood plasma.

Concentrations of progesterone, estrogen, and prolactin in plasma were compared among lactations induced in 29 cows by daily subcutaneous injections of .25 mg progesterone and .1 mg estradiol-17beta per kg body weight for 7 days. Superior, median, and inferior lactations were identified by ranking both weightage adjusted maximum milk yields in 7 consecutive days (average 144 +/- 9 kg) and days for milk yield to increase from 5 to 10 kg/day (15 +/- 3 days). Superior and inferior of the former averaged 189 and 101 kg, and their latter averaged 2 and 42 days. Plasma hormones were measured on day 0 before first treatment (day 1), and on days 7, 14, 17, 21, 24, 28, and 35. Superior lactations were associated with below-average progesterone and estrogen in plasma on day 0, rapid decreases in progesterone after day 7 and in estrogen after day 14, and increased prolactin after 7. In comparison, median lactations were associated with elevated progesterone and estrogen after day 17, but prolactin was similar to that of superior lactations. Inferior lactations were associated with decreased prolactin in plasma from days 21 to 35. We hypothesized that (a) first treatment should start 3 to 8 days after estrus, (b) daily doses of estradiol-17beta should be decreased with progesterone unchanged for the 7 days, and (c) estradiol-17beta alone should be continued for 7 days to improve hormonally induced lactations.

Relationships between immunoreactive estrone and estradiol in milk, blood, and urine of dairy cows.

Quantities of immunoreactive estrone and estradiol in blood plasma, urine, and milk were measured during the estrous cycle and pregnancy of cows. The objectives were to develop a radioimmunoassay procedure for quantifying estrogen in milk and urine and to compare changes in milk estrogen with those in blood plasma and urine. Concentrations of estrone and estradiol in milk varied during the estrous cycle. Relative concentrations of estradiol in blood plasma and milk were not different, but average estrone concentrations in milk were four times greater than those in blood plasma. Concentration of total estrogen (estradiol plus estrone) exceeded 1 ng/ml in colostrum and milk from cows milked prepartum, and was correlated with total estrogen in blood plasma and urine before and after calving. Blood plasma estrone was correlated only with milk estrone whereas blood plasma estradiol was correlated with urinary estradiol, milk estrone, and milk estradiol during the estrous cycle. These results raise possibilities that mammary gland of the lactating cow may concentrate preferentially estrone or convert estradiol to estrone. However, estimated excretion of estrogen through the milk represents no more than a fraction of 1% of the total excreted during the estrous cycle, and the proportion becomes less as gestation progresses up to at least 7 mo.